Mutations in the BRCA1 and BRCA2 tumour suppressor genes are associated with prostate
cancer risk; however, optimal screening protocols for individuals with these mutations have …

Purpose: Castration-sensitive prostate cancer (CSPC) is a complex and heterogeneous
condition encompassing a range of clinical presentations. As new approaches have …

Introduction: Health care procedures including cancer screening and diagnosis were
interrupted due to the COVID-19 pandemic. The extent of this impact on cancer care in the …

PURPOSE: Germline testing for men with prostate cancer (PCa) poses numerous
implementation barriers. Alternative models of care delivery are emerging, but …

Background Although TP53 and SPOP are frequently mutated in metastatic prostate cancer
(PCa), their prognostic value is ambiguous, and large sample studies are lacking, especially …

Objectives To evaluate different scenarios for the management of early diagnosis of cancer
(PCa) in men at high genetic risk, using recently developed blood and urinary molecular …

Inter-professional collaboration could improve timely access and quality of oncogenetic
services. Here, we present the results of a scoping review conducted to systematically …

Prostate cancer is characterized by several genetic alterations which could impact prognosis
and therapeutic decisions in the advanced disease. Tissue biopsy is still considered the …

PURPOSE Telegenetics services can expand access to guideline-recommended cancer
genetic testing. However, access is often not distributed equitably to all races and ethnicities …

Purpose Prostate cancer (CaP) is the most common cancer in Black men (BM), and the
number of Black CaP survivors is rapidly increasing. Although Black immigrants are among …